Diabetic Peripheral Neuropathy (DPN) Completed Phase Trials for Exenatide (DB01276)

Also known as: Diabetic Neuropathy Peripheral / Peripheral Diabetic Neuropathy / Diabetic Peripheral Neuropathy / Peripheral neuropathy due to diabetes mellitus (disorder) / Diabetic neuropathy / Diabetic Neuropathies / Diabetes + neuropathy (& [amyotrophy]) / Diabetic neuropathy (disorder) [Ambiguous] / Diabetic neuropathy &/or diabetic polyneuropathy / Diabetes mellitus with neurological manifestation: (& [amyotrophy] or [neuropathy] or [polyneuropathy]) / Diabetes mellitus NOS with neurological manifestation (disorder) / Neuropathy due to diabetes mellitus (disorder)

IndicationStatusPhase
DBCOND0049986 (Diabetic Peripheral Neuropathy (DPN))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00855439Evaluation of Exenatide in Patients With Diabetic NeuropathyTreatment